Masaru Matsuda files SEC Form 4 disclosures for Arcutis Biotherapeutics, Inc.. They have made 16 open-market trades across 1 company since 2022, most recently 2026-09-16.
CIK 0001798679
1 open-market purchase totalling $19K since 2024, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARQT | 112,508 | $3.2M |
| HALO | 23,461 | $2.9M |
| Total | $6.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARQT | SELL · 10b5-1 | 2026-09-16 | 2026-09-18 | $25.00 | $92K | +3.8% | — | — |
| ARQT | SELL · 10b5-1 | 2026-09-08 | 2026-09-10 | $25.03 | $250K | +15.7% | +9.3% | — |
| ARQT | SELL | 2026-08-03 | 2026-08-05 | $26.12 | $32K | -11.8% | -17.7% | — |
| ARQT | SELL · 10b5-1 | 2026-05-04 | 2026-05-06 | $23.31 | $192K | -12.4% | -7.2% | +13.8% |
| ARQT | SELL · 10b5-1 | 2026-02-27 | 2026-03-03 | $26.03 | $314K | -3.0% | +0.8% | -8.3% |
| ARQT | SELL | 2026-02-02 | 2026-02-04 | $25.28 | $1.0M | +1.6% | -8.3% | -10.5% |
| ARQT | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $30.23 | $100K | -1.4% | -1.3% | -19.7% |
| ARQT | SELL | 2025-11-19 | 2025-11-21 | $28.29 | $72K | +4.4% | +0.2% | -6.3% |
| ARQT | SELL | 2025-11-03 | 2025-11-05 | $24.71 | $355K | +9.4% | +30.4% | +9.4% |
| ARQT | SELL · 10b5-1 | 2025-09-04 | 2025-09-08 | $16.16 | $1.2M | +2.8% | +23.3% | +80.1% |
| ARQT | SELL | 2025-08-04 | 2025-08-05 | $14.33 | $181K | +12.2% | +7.7% | +64.5% |
| ARQT | SELL | 2025-05-28 | 2025-05-29 | $13.78 | $25K | +2.5% | +3.5% | +15.5% |
| ARQT | SELL · 10b5-1 | 2025-05-02 | 2025-05-05 | $15.20 | $76K | -9.0% | -11.4% | -3.0% |
| ARQT | SELL | 2025-03-03 | 2025-03-04 | $13.03 | $43K | +9.5% | +21.0% | +1.0% |
| ARQT | SELL | 2025-02-03 | 2025-02-04 | $12.70 | $212K | -2.7% | +10.4% | +17.4% |
| ARQT | SELL | 2024-11-19 | 2024-11-19 | $9.68 | $17K | +22.0% | +38.6% | +22.9% |
| ARQT | SELL | 2024-11-04 | 2024-11-05 | $8.68 | $44K | -1.2% | +31.4% | +35.4% |
| ARQT | SELL · 10b5-1 | 2024-08-02 | 2024-08-05 | $9.02 | $47K | -6.6% | +14.9% | -4.2% |
| ARQT | BUY | 2024-05-31 | 2024-12-03 | $3.28 | $19K | +1.6% | +16.6% | +2.7% |
| ARQT | SELL | 2024-05-28 | 2024-05-29 | $9.01 | $16K | -13.2% | +7.0% | +21.2% |
| ARQT | SELL · 10b5-1 | 2024-05-02 | 2024-05-03 | $8.74 | $44K | +16.7% | +3.2% | +19.7% |
| ARQT | SELL · 10b5-1 | 2024-03-04 | 2024-03-06 | $11.12 | $42K | -2.8% | +7.6% | -25.2% |
| ARQT | SELL | 2023-11-21 | 2023-11-21 | $1.98 | $4K | +14.9% | +33.3% | +386.2% |
| ARQT | SELL | 2023-05-31 | 2023-06-02 | $7.80 | $14K | +31.5% | +7.6% | +5.0% |
| ARQT | SELL · 10b5-1 | 2023-03-02 | 2023-03-06 | $15.83 | $23K | -23.4% | -23.3% | -40.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.